Stroke Trial, Recruiting NCT06962397 Sponsor: Federal Center of Cerebrovascular Pathology and Stroke, Russian Federation Ministry of Health Condition: Stroke
Back to Stroke

Stroke Trial, Recruiting

NCT06962397
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • A stroke has been confirmed by a brain scan (such as an MRI or CT scan)
  • The stroke occurred more than one month ago
  • A score of 20 or higher on a standard memory and thinking test called the Montreal Cognitive Assessment (MoCA)
  • A score of 3 or higher on the Barthel Index, which measures ability to carry out daily activities
  • Able to understand and follow instructions during the trial
  • Willing to give consent to take part and allow data to be collected
  • Aged between 18 and 80 years old

Who may not be able to join:

  • People showing significant signs of depression, based on a score above 11 on the depression portion of a questionnaire called the HADS
  • People with arm weakness below a certain level, based on a score under 35 on a standard arm movement assessment called the Fugl-Meyer scale
  • People whose sense of feeling in their arm or hand falls outside an acceptable range, based on a Fugl-Meyer sensory score below 3 or above 10 (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Galina Ivanova, Professor, Federal Center of Cerebrovascular Pathology and Stroke, Russian Federation Ministry of Health

Phone: +79162528715

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Federal Center of Cerebrovascular Pathology and Stroke, Russian Federation Ministry of Health
Registry
ClinicalTrials.gov
Start date
8 October 2024
Est. completion
1 June 2025

Where this trial is recruiting

🇷🇺 Russia

Primary endpoints

Change in Tactile Sensitivity of the Affected Index Finger

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov